Share on LinkedInShare on LinkedIn

ARTICLE · 21 DECEMBER 2015

Canadian Court Nixes Class Action For Patent Abuse

Blake, Cassels & Graydon LLP
Blake, Cassels & Graydon LLP
Contributor
Blake, Cassels & Graydon LLP

Blake, Cassels & Graydon LLP

As one of Canada’s top business law firms, Blake, Cassels & Graydon LLP (Blakes) provides...

View firm profile
Explore more from Blake, Cassels & Graydon LLP

The British Columbia Court of Appeal (BCCA), in Low v. Pfizer Canada Inc.​, has held that Canada's Patent Act provides a complete code that forecloses civil actions by consumers centred on breaches of the statute.

CanadaIntellectual Property

The British Columbia Court of Appeal (BCCA), in Low v. Pfizer Canada Inc., has held that Canada's Patent Act provides a complete code that forecloses civil actions by consumers centred on breaches of the statute.

BACKGROUND

The decision relates to an application to certify a proposed class action, commenced by a representative plaintiff, Britton Low, against various Pfizer companies, alleging that Pfizer unlawfully abused the patent system with the result that purchasers of the drug VIAGRA were overcharged. The proposed class consists of B.C. purchasers of VIAGRA during the period of January 1, 2006 to November 30, 2012.

Mr. Low relied on the fact that Pfizer's patent for VIAGRA had been held to be invalid for insufficiency by the Supreme Court of Canada and the Federal Court. He therefore alleged that Pfizer's actions in enforcing its patent so as to prevent generic versions of VIAGRA from being marketed prior to the declaration of invalidity of the Pfizer

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from